Global Scientific Recognition for M3CRC with Invited Presentation by Prof. Francis Chan at EHMSG 2025
We’re proud to annouce that our Co-founder, Professor Francis Chan, was invited to present our multi-centre study of M3CRC in Asia at EHMSG 2025, Europe’s leading summit on microbiome and gastrointestinal health.
The study, involving over 2,000 subjects across Asia, demonstrates that our microbial gene marker panel outperforms FIT in detecting advanced colorectal neoplasia. The presentation drew strong interest from European experts.
Among them was Professor Laurence Zitvogel (pictured in white), Chair of the Oncobiome session and a globally renowned clinical oncologist and immunologist from the Laboratory of Tumor Immunology and Immunotherapy at Paris-Saclay University. She remarked that the study could have a huge impact in Europe, offering powerful validation of our work and its clinical relevance.
We are now collaborating with leading centres in France, Germany, Italy, and the UK to validate M3CRC across diverse populations in multiple European countries, accelerating our path toward clinical adoption across the region.
#MicroSigX #M3CRC #EHMSG2025 #ColorectalCancer #MicrobiomeDiagnostics #ScientificLeadership #CancerScreening #BiotechInnovation #GlobalHealth
